MSI2 is required for maintaining activated myelodysplastic syndrome stem cells
Several studies have recently demonstrated the role of the MSI2 RNA binding protein in normal and malignant haematopoietc stem cells. In this study, the authors show that MSI2 is required for maintaining myelodysplastic syndrome stem cells in mice and that MSI2 expression predicts poor prognosis in...
Guardado en:
Autores principales: | James Taggart, Tzu-Chieh Ho, Elianna Amin, Haiming Xu, Trevor S. Barlowe, Alexendar R. Perez, Benjamin H. Durham, Patrick Tivnan, Rachel Okabe, Arthur Chow, Ly Vu, Sun Mi Park, Camila Prieto, Christopher Famulare, Minal Patel, Christopher J. Lengner, Amit Verma, Gail Roboz, Monica Guzman, Virginia M. Klimek, Omar Abdel-Wahab, Christina Leslie, Stephen D. Nimer, Michael G. Kharas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c73f9725b9740dfbe30b10dcaac4d49 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Caribbean Msi+5 Regional Review
Publicado: (2015) -
Clonal evolution in myelodysplastic syndromes
por: Pedro da Silva-Coelho, et al.
Publicado: (2017) -
TP53 in Myelodysplastic Syndromes
por: Yan Jiang, et al.
Publicado: (2021) -
Managing myelodysplastic symptoms in elderly patients
por: R Ria, et al.
Publicado: (2009) -
The genomic landscape of pediatric myelodysplastic syndromes
por: Jason R. Schwartz, et al.
Publicado: (2017)